12 employees
Aegirbio is a Swedish diagnostics company offering tests to monitor and optimize the dosing of biological drugs.
2019
$1.2M
from 1 investors over 1 rounds
Aegirbio raised $1.2M on October 6, 2023
Investors: National Institutes of Health